Xuekang Pan - Publications

The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights.

Journal: Frontiers in immunology

Published: January 17, 2026

Modified percutaneous vertebral body-intervertebral disc biopsy combined with genetic testing for the diagnosis of early-stage pyogenic spondylodiscitis: a retrospective cohort study.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: October 10, 2025

Triptolide alleviates rheumatoid arthritis via modulating gut microbiota - intestinal barrier - TLR4/NF-κB axis.

Journal: Open life sciences

Published: May 28, 2025

Tripterygium wilfordii multi-glycoside alleviates ankylosing spondylitis via gut microbiota modulation and metabolite reprogramming.

Journal: Journal of advanced research

Published: April 16, 2025

4-Octyl itaconate protects chondrocytes against IL-1β-induced oxidative stress and ferroptosis by inhibiting GPX4 methylation in osteoarthritis.

Journal: International immunopharmacology

Published: February 12, 2024

Intracellular Delivery of Itaconate by Metal-Organic Framework-Anchored Hydrogel Microspheres for Osteoarthritis Therapy.

Journal: Pharmaceutics

Published: December 23, 2022

"Early Efficacy and Safety of Unilateral Biportal Endoscopic Lumbar Interbody Fusion Versus Minimal Invasive in the Treatment of Lumbar Degenerative Diseases".

Journal: Clinical spine surgery

Published: July 26, 2022

Four-octyl itaconate improves osteoarthritis by enhancing autophagy in chondrocytes via PI3K/AKT/mTOR signalling pathway inhibition.

Journal: Communications biology

Published: July 20, 2021